Earnings Preview: LAB to Report Financial Results Post-market on May 06
Express News | Standard BioTools - Launches New Proteomic Products
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
Express News | Sight Sciences Appoints Gary Burbach to Its Board of Directors
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Standard BioTools | 10-K: FY2024 Annual Report
Insider Purchase: Director at $LAB Buys 4,820,959 Shares
Casdin Partners Master Fund Buys $5.13 Million in Standard BioTools Stock
Standard BioTools(LAB.US) 10% Shareholder Buys US$5.13 Million in Common Stock
Analysts Have Lowered Expectations For Standard BioTools Inc. (NASDAQ:LAB) After Its Latest Results
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Shares Fall After Downgrade From KeyBanc
Standard BioTools Analyst Ratings
Express News | Standard BioTools Down 8.6% Premarket After Wider-Than-Forecast Q4 Loss
KeyBanc Downgrades Standard BioTools to Sector Weight From Overweight, Removes $4 Price Target
KeyBanc Downgrades Standard BioTools(LAB.US) to Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Standard BioTools (LAB) and Ardent Health Partners, Inc. (ARDT)
Earnings Call Summary | Standard BioTools(LAB.US) Q4 2024 Earnings Conference